- Email: [email protected]
1210. Retroviral Gene Transfer of the WASP Gene to Lymphoblastoid B Cells of Wiskott-Aldrich Syndrome Patients. Evaluation of Phenotypic Correction
!" / 3
ΔD* @
3 @
*'$!C 3
*2 " 3
-!2/ *
2# 3 ?4"(
)*) 3
ΔD* ?@ 3 ;6":8H 3 " " &
"
2#
=8"66H *2 J
' 6 H 3 " &&H - 8:":;H/ =8H - 8&" ;,H/
=
" !2
3 ΔD* ?@
3 " >3 8,
" ΔD* ?@
!2 2# ≈B9H 58
*'$!C 3
≈:9H ' ?4"(
ΔD* ?@
3
" 1
3 ! 3 ΔD* ?@ 58
?4"( (*)+() )
(??."
(! D ( " 3 58 ΔD* ?@
2# 3
" * 1 3
1209. Functional Analysis of an Insulated Oncoretrovirus V ector for Human Gamma-Globin in Vector Mouse Models for Beta Thalassemia Tamon Nishino,1 Evangelia Yannaki,2 Julie Tubb,1 Qiliang Li,1 George Stamatoyannopoulos,1 David W. Emery.1 1 Department of Medicine, University of Washington, Seattle, WA, United States; 2Hematology /BMT Unit, G. Papanikolaou General Hospital, Thessaloniki, Greece. 0
"
"
" " C 3 3
1
" C(6 Q!*'( 5;758&9 ,999R 3 ' B
-2B$,?8/
3
" @2 65±,9H
3
" @2 ,"&H
@*
" 3
,=±8BH " -BH "/
@2 0
3
G -C "=%J/ '8 " ,5±:H -M5/ @2 3
" '
3
@2 ,5" 3
@2 3 " E C
,&H "
3 @2 -M6/ @2 -=:±98389B% ,B±88389B% B9±8:389B% / -B;±9, % 6;±85 % Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
8,,±== % / 0
" E ?
G -C "=%C "=/
&;2DB 0
" -M8=/
=6±,9
8B±; "
-M999B/ C(6 3 89" " 3
1210. Retroviral Gene T ransfer of the W ASP Gene to Transfer WASP Lymphoblastoid B Cells of Wiskott-Aldrich Syndrome Patients. Evaluation of Phenotypic Correction Nuria Andreu,1,2 Josep M. Aran,1 Xavier Estivill,1,2 Cristina Fillat.1,2 1 Centre de Genetica Medica i Molecular, Institut de Recerca Oncològica, Hospitalet de Llobregat, Barcelona, Spain; 2 Programa Gens i Malaltia, Centre de Regulació Genòmica, Barcelona, Barcelona, Spain. 0 "' -0'(/ F"
0 "' ( ! -0'(!/ G
0'(
CD'"
0'( 0
86
( ,9
88
# @:BC >8==A
0'(! 3 @:BC
3 0'(! >8==A
3 0'(!
0'(
0'(! $*' > "2 ->2./" 0'( @:BC >8==A
68: >3
0 ?"
3
E
# 3 0'(!
0'(!"
0'(!
121 1. Gene Therapy of Fanconi Anemia Groups A and 1211. C by Lentiviral V ectors Using Mouse as an Experimental Vectors Model: Comparison with Retroviral V ectors Vectors Meenakshi Noll,1 Francesco Galimi,2 Yoshiyuki Kanazawa,2 Timothy Lax,1 Alan D′Andrea,3 Inder Verma,2 Markus Grompe.1 1 Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon, United States; 2Genetics, The Salk Institute, La Jolla, California, United States; 3Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. ? ' -?'/ G
$*' "
2 -2# /
? ' CD'"
C 2#
?' 1 ?'
3
!
?'
S393
ΔD* @
3 @
*'$!C 3
*2 " 3
-!2/ *
2# 3 ?4"(
)*) 3
ΔD* ?@ 3 ;6":8H 3 " " &
"
2#
=8"66H *2 J
' 6 H 3 " &&H - 8:":;H/ =8H - 8&" ;,H/
=
" !2
3 ΔD* ?@
3 " >3 8,
" ΔD* ?@
!2 2# ≈B9H 58
*'$!C 3
≈:9H ' ?4"(
ΔD* ?@
3
" 1
3 ! 3 ΔD* ?@ 58
?4"( (*)+() )
(??."
(! D ( " 3 58 ΔD* ?@
2# 3
" * 1 3
1209. Functional Analysis of an Insulated Oncoretrovirus V ector for Human Gamma-Globin in Vector Mouse Models for Beta Thalassemia Tamon Nishino,1 Evangelia Yannaki,2 Julie Tubb,1 Qiliang Li,1 George Stamatoyannopoulos,1 David W. Emery.1 1 Department of Medicine, University of Washington, Seattle, WA, United States; 2Hematology /BMT Unit, G. Papanikolaou General Hospital, Thessaloniki, Greece. 0
"
"
" " C 3 3
1
" C(6 Q!*'( 5;758&9 ,999R 3 ' B
-2B$,?8/
3
" @2 65±,9H
3
" @2 ,"&H
@*
" 3
,=±8BH " -BH "/
@2 0
3
G -C "=%J/ '8 " ,5±:H -M5/ @2 3
" '
3
@2 ,5" 3
@2 3 " E C
,&H "
3 @2 -M6/ @2 -=:±98389B% ,B±88389B% B9±8:389B% / -B;±9, % 6;±85 % Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy
8,,±== % / 0
" E ?
G -C "=%C "=/
&;2DB 0
" -M8=/
=6±,9
8B±; "
-M999B/ C(6 3 89" " 3
1210. Retroviral Gene T ransfer of the W ASP Gene to Transfer WASP Lymphoblastoid B Cells of Wiskott-Aldrich Syndrome Patients. Evaluation of Phenotypic Correction Nuria Andreu,1,2 Josep M. Aran,1 Xavier Estivill,1,2 Cristina Fillat.1,2 1 Centre de Genetica Medica i Molecular, Institut de Recerca Oncològica, Hospitalet de Llobregat, Barcelona, Spain; 2 Programa Gens i Malaltia, Centre de Regulació Genòmica, Barcelona, Barcelona, Spain. 0 "' -0'(/ F"
0 "' ( ! -0'(!/ G
0'(
CD'"
0'( 0
86
( ,9
88
# @:BC >8==A
0'(! 3 @:BC
3 0'(! >8==A
3 0'(!
0'(
0'(! $*' > "2 ->2./" 0'( @:BC >8==A
68: >3
0 ?"
3
E
# 3 0'(!
0'(!"
0'(!
121 1. Gene Therapy of Fanconi Anemia Groups A and 1211. C by Lentiviral V ectors Using Mouse as an Experimental Vectors Model: Comparison with Retroviral V ectors Vectors Meenakshi Noll,1 Francesco Galimi,2 Yoshiyuki Kanazawa,2 Timothy Lax,1 Alan D′Andrea,3 Inder Verma,2 Markus Grompe.1 1 Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon, United States; 2Genetics, The Salk Institute, La Jolla, California, United States; 3Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. ? ' -?'/ G
$*' "
2 -2# /
? ' CD'"
C 2#
?' 1 ?'
3
!
?'
S393